Primary biliary cirrhosis is a typical autoimmune disease with a strong genetic component.
Genome-wide studies have greatly expanded understanding of genetic risk.
This review highlights individual associations including HLA types and the IL-12-STAT4 pathway.
Animal models, epigenetics and novel immunological therapies are also considered.